← All stocks

BiomX Inc.

PHGE Net buying
CIK 0001739174 #5600 in the set updated 19 Sep 2026
Bought (120 mo)
$785.89K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.58M
$0.00 on a plan · $8.26M straight out of an exercise
Sold at will
$322.16K
65 of 70 sales
Net
−$7.80M
+$463.73K against sales at will

By person

18 insiders · 104 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Yeganeh Reuven
Director
$8.25M (4) scheduled
−$8.25M
0
$0.00
Ugwumba Chidozie
Exit Form 4 - former 10% owner
$318.09K (62)
−$318.09K
2,997,025
$14.99M
−17.6%
OrbiMed Israel BioFund GP Limited Partnership entity
10% owner
$284.44K (9)
$9.28K (1) scheduled
+$275.16K
16,587,142
$82.94M
+156.8%
Chimovits Erez
Director
$199.18K (7)
+$199.18K
4,626,978
$23.13M
+0.5%
Solomon Jonathan Eitan
Chief Executive Officer
$100.00K (1)
+$100.00K
126,748
$633.74K
SEKHRI PAUL J
Director
$50.00K (1)
+$50.00K
12,500
$62.50K
Sullivan Lynne Marie
Director
$50.00K (1)
+$50.00K
12,500
$62.50K
GROSSMAN JONAS
Director
$49.24K (4)
+$49.24K
2,079,717
$10.40M
−39.1%
Moses Alan Charles
Director
$20.00K (1)
+$20.00K
5,000
$25.00K
Greig Russell
Director
$15.00K (1)
+$15.00K
3,750
$18.75K
Wolfson Marina
Chief Financial Officer
$15.00K (1)
+$15.00K
68,545
$342.73K
Oron Assaf
Chief Business Officer
$3.03K (3)
$4.07K (3)
−$1.04K
25,804
$129.02K
Amusa Gbolahan
Director
(1)
$0.00
262,871
$1.31M
Cystic Fibrosis Foundation entity
10% owner
9,330,580
$46.65M
+105.0%
Flynn James E
Director
1,247,054
$6.24M
PROPPER KERRY
10% owner
260,771
$1.30M
Bassan Merav
Chief Development Officer
79,597
$397.99K
Walton Thomas Layton
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 10,111,516 to 29,006,165 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Oron Assaf
22 May 2023
Chief Business Officer
Buy
3,192
$0.27
$871.74
Oron Assaf
19 May 2023
Chief Business Officer
Buy
6,521
$0.28
$1.83K
Oron Assaf
18 May 2023
Chief Business Officer
Buy
1,201
$0.27
$327.51
OrbiMed Israel BioFund GP Limited Partnership
27 Feb 2023
10% owner
Buy indirect
348,000
$0.25
$85.26K
Moses Alan Charles
28 Jul 2021
Director
Buy
5,000
$4.00
$20.00K
SEKHRI PAUL J
28 Jul 2021
Director
Buy
12,500
$4.00
$50.00K
Greig Russell
28 Jul 2021
Director
Buy indirect
3,750
$4.00
$15.00K
Solomon Jonathan Eitan
28 Jul 2021
Chief Executive Officer
Buy
25,000
$4.00
$100.00K
Sullivan Lynne Marie
28 Jul 2021
Director
Buy
12,500
$4.00
$50.00K
Wolfson Marina
28 Jul 2021
SVP of Finance & Operations
Buy
3,750
$4.00
$15.00K
OrbiMed Israel BioFund GP Limited Partnership
28 Jul 2021
10% owner
Buy indirect
500,000
no price
Amusa Gbolahan
26 Jul 2021
Director
Buy
25,000
no price
GROSSMAN JONAS
26 Jul 2021
Director
Buy
37,500
no price
Chimovits Erez
19 Dec 2019
Director
Buy indirect
3,500
$8.90
$31.15K
OrbiMed Israel BioFund GP Limited Partnership
19 Dec 2019
Director
Buy indirect
3,500
$8.90
$31.15K
Chimovits Erez
18 Dec 2019
Director
Buy indirect
500
$8.93
$4.47K
OrbiMed Israel BioFund GP Limited Partnership
18 Dec 2019
Director
Buy indirect
500
$8.93
$4.47K
OrbiMed Israel BioFund GP Limited Partnership
11 Dec 2019
Director
Buy indirect
5,400
$8.92
$48.17K
Chimovits Erez
11 Dec 2019
Director
Buy indirect
5,400
$8.92
$48.17K
OrbiMed Israel BioFund GP Limited Partnership
10 Dec 2019
Director
Buy indirect
3,400
$8.75
$29.75K
Chimovits Erez
10 Dec 2019
Director
Buy indirect
3,400
$8.75
$29.75K
Chimovits Erez
9 Dec 2019
Director
Buy indirect
6,000
$8.68
$52.08K
OrbiMed Israel BioFund GP Limited Partnership
9 Dec 2019
Director
Buy indirect
6,000
$8.68
$52.08K
Chimovits Erez
6 Dec 2019
Director
Buy indirect
800
$8.00
$6.40K
OrbiMed Israel BioFund GP Limited Partnership
6 Dec 2019
Director
Buy indirect
800
$8.00
$6.40K
Chimovits Erez
5 Dec 2019
Director
Buy indirect
3,400
$7.99
$27.17K
OrbiMed Israel BioFund GP Limited Partnership
5 Dec 2019
Director
Buy indirect
3,400
$7.99
$27.17K
GROSSMAN JONAS
20 Nov 2019
Director
Buy
1,400
$8.00
$11.21K
GROSSMAN JONAS
19 Nov 2019
Director
Buy
4,100
$7.57
$31.05K
GROSSMAN JONAS
18 Nov 2019
Director
Buy
1,000
$6.99
$6.99K

What was left out

Form 4 filings counted 121
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 65
Transactions with no price 3
Shares from compensation/vesting 42,932,639
Sales filed before the plan box existed 62
History held since 19 Dec 2018